Unlocking the Future of the Neuropathic Pain Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
Analyzing the Growth Rate of the Neuropathic Pain Market: What’s the Expected CAGR for the Next Decade?
In the past few years, the neuropathic pain market size has seen robust growth. The market that was valued at $5.35 billion in 2024 is predicted to reach $5.79 billion by 2025, growing at a compound annual growth rate (CAGR) of 8.2%. The amplified demand for neuropathic pain medicines, the persistent pain epidemic, increased desire for prescription therapies, and government schemes have all contributed to the historical growth period.
The market size of neuropathic pain is anticipated to witness a robust increase in the coming years, reaching a substantial value of $7.76 billion by 2029 at a compound annual growth rate (CAGR) of 7.6%. This growth, expected in the forecasted period, can be credited to factors such as rising awareness of neuropathic pain, an expanding elderly population, an extensively developed healthcare sector, and easy accessibility to treatments for neuropathic pain. Noteworthy trend projections for this estimated period encompass enhanced diagnostic procedures, progress in pain management tactics, advancement in medical research, approvals for new drugs, and strategic initiatives.
What Factors Are Propelling the Growth of the Neuropathic Pain Market from 2025 to 2034?
Increasing chronic pain prevalence is set to stimulate the neuropathic pain market’s expansion. Chronic pain is a persistent agony that exceeds the predicted recovery period of an ailment or injury and usually lasts at least three to six months. This rising prevalence of chronic pain, inclusive of neuropathic conditions, necessitates efficient treatments, kindling the need for research, innovation, and investment into developing better therapies for symptom relief and raising patients’ quality of life. An example is from the Scottish Health Survey 2022, released by a Scottish Government department in December 2023, which revealed that over one-third (38%) of Scottish adults in 2022 experienced pain or discomfort for three months or longer, with a higher proportion among women (43%) than men (33%). Consequently, the escalating prevalence of chronic pain propels the growth of the neuropathic pain market.
Neuropathic Pain Market Driver: Propelling the Neuropathic Pain Market through the Predicted Increase in Diabetes Cases
Explore Comprehensive Insights Into The Global Neuropathic Pain Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12922&type=smp
What Are the Leading Organizations Impacting the Neuropathic Pain Market’s Growth?
Major companies operating in the neuropathic pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Medtronic Inc., Eli Lilly and Company, Stryker Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Biogen Inc., Zimmer Biomet Holdings Inc., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., NuVasive Inc., Integer Holdings Corporation, Avanos Medical Inc., Orthofix Medical Inc., Nevro Corp., InvaGen Pharmaceuticals Inc., B. Braun Melsungen AG, Cirtec Medical Corp., Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, DePuy Synthes.
What Are the Most Prominent Trends Driving Change in the Neuropathic Pain Market?
Leading firms in the neuropathic pain market are turning to artificial intelligence to enhance diagnostic processes, personalize treatment strategies, monitor patients in real time, aid in drug discovery, and gain insightful data. As an example, Nevro Corp., a medical device company from the US, introduced the Senza HFX iQ spinal cord stimulation (SCS) system in March 2023. This innovative system utilizes AI to provide pain relief tailored to each patient. The Senza HFX iQ system, including the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger, and HFX App, is specifically designed for managing non-surgical back pain and painful diabetic neuropathy. It adapts to patient responses and allows patients to modify their pain control program using a mobile app. The system operates in a digital environment for data collection and potential updates. With an emphasis on constancy and personalization, the technology represents a major progression in SCS treatment.
Secure Your Global Neuropathic Pain Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
How Are Market Segments in the Neuropathic Pain Industry Positioned for Long-Term Growth?
The neuropathic pain market covered in this report is segmented –
1) By Treatment: Medications, Multimodal Therapy
2) By Diagnosis: Imaging, Blood Tests And Physical Examination
3) By Indication: Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications
4) By End User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Medications: Anticonvulsants, Antidepressants, Opioids, Topical Treatments, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Multimodal Therapy: Combination Of Medications, Physical Therapy, Psychological Therapy, Lifestyle Modifications, Complementary Therapies
What Regions Are Leading the Charge in the Neuropathic Pain Market?
North America was the largest region in the neuropathic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does the Definition of the Neuropathic Pain Market Include?
Neuropathic pain is chronic pain caused by damage or dysfunction in the nervous system and characterized by burning, tingling, shooting, or electric shock-like sensations. Neuropathic pain can be challenging to treat and may be caused by nerve injuries, diabetes, multiple sclerosis, nerve compression, neural degeneration and central nervous system disorders.
Browse Through More Similar Reports By The Business Research Company:
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Nerve Repair And Regenerative Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report
Neurophysiology Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
